The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
One way forward for EQT to accelerate in geographic areas outside Europe would be to partner with bigger firms like Wood with the resources and capabilities in potential new markets. EQT don't have the resources and finances to go it alone with the huge potential in store. Hopefully today's Glasgow event will see even more interest.
If it comes to a take over, perhaps Wood will be a candidate?
Looking forward to seeing published Q&A which Investor Meet do well. Yes a bit surprised CFO went as far on future revenues but this underlines growth potential.
Shareholders with 3% + as at 30 September total just under 50% as below. There ought to be more Institutional interest and probably Singer's appointment and more impetus could see movement.
Balderton Capital III, LP (1) 6,813,196 9.9%
Blind Trust (Richard Sharp) 4,447,000 6.4
Credit Suisse 3,937,196 5.7
Chelverton Asset Management 3,889,391 5.6
Dr Adam M Hill (2) 3,537,539 5.1
Genostics Company Ltd 3,335,659 4.8
Mr Timothy Brian Bunting 2,956,717 4.3
UBS Securities 2,843,288 4.1
Hargreaves Lansdown Asset Management 2,401,712 3.5
Update confirms there is a lot to come in next 6 months and hoping expectations are met. Added 2k to get back to 40k holding.
is a full update similar to the one on 8 June 2021 with as much detail as possible - of course assuming its good news! I wish all companies on AIM were required to provide quarterly updates as required in some other jurisdictions.
Undoubtedly strategic with additional geographic scope and significant in size and potential but may not move SP much due to lack of detail on t/o and value generated. Also the pipeline would benefit from an update assuming more contracts have been signed.
Anyway another building block to a larger and more valuable business with a lot more expected by the end of 2022.
So results from three drill holes have been reasonable and there are another 10 or 12 drill holes in Phase 2 on which assay results will follow. Is this correct?
Then there are another 13 drills in the second phase due to be carried out this year using two rigs. If any company is going to produce a significant news flow then this is it!
In the excellent full year trading update in June ONC stated they expected FY21 (y/e 31 May 2021) results to be released in September so the results are overdue. Last year results came out on 30 October so there seems a delay. One improvement for ONC is to make more regular updates given the large number of developments and pipeline. As a holder of almost 40k shares, I would welcome better communication and PR.
Only managed to hear the first part and GB seemed very positive. Presentation shows significant potential value in SA. Was there any update on Burundi? Over 10 weeks since last update in August. It is not hugely significant (unless scaled up in a big way) but provides income and pays for group overheads.
Excellent interview and set out the wider scope of Destiny and near term developments. P3 is not far away and preparations and collaborations should be news in Q4 hopefully. Given the area Destiny are in and the stage reached , it is surprising there is not more interest and buyers.
250k purchase at 2.09 shows as a sell. Misleading when looking at pattern of trades.
why the SP and Mcap dropped by so much albeit the 25p placing was at a huge discount. Used to be in but luckily sold out at the right time. Not a trader but will take profits. Last profit on this has been reinvested to buy 40k shares but shown as a sell just now.
Will listen to event on 19th although I believe Loop can only go up from here with the technology and new contract pipeline. Most interested to hear what revenue projections are for next FY and costs elements.
Getting this plant up and running is a major milestone and success would open up a huge opportunity in California and other States - a likely game-changer for EQT in USA and elsewhere.
Cannot see any reference to expected commissioning dates in RNS. Is it possible in Q4?
Yes - 20k more at 4.23 shown as a sell on LSE
Huge number of share trades - over 15,000. Obviously great uncertainty over which way the company and SP will go next. The Board and senior management must be gobsmacked and very alarmed at the outcome of and market reaction to the CME> Will be fascinating to see what happens next and how the company respond to the questions and doubts raised. They will have to do a number of things to address the concerns and demonstrate their skills to turn around the doubters. Major investors are key especially SB.
One action they should take but may not be able to short term is sack their advisers who helped them with this poo show and the proposal for a separate listing for THB. Perhaps cancelling or postponing will help. The SBM arrangement is not a separate listing so should not affect the group structure. IF SB pull back then the issues will be possibly overwhelming.
Next few days and weeks will be revealing.
Still hoping for update this week based on timing of Q3 updates in last two years. SP can be news driven and with higher gas prices the numbers may look very good.
no mention of engagement with major shareholders. Hoping that there will be some contact and that no major shareholders are selling out. MR sets out a very ambitious strategy that will require quite a lot of money. It remains to be seen if fund raising will mean dilution. At least the company will have significantly increased revenue from the higher gas prices and hopefully be allowed on shore drilling in Tesorillo as that would be a potential game changer.
Impressed with Q&A with 150 items - longest ever in history of AIM may be? The key question is whether more funds will be required in 2022 if the commercialisation takes longer than expected. It seems almost everything takes longer except a fall in SP!
In last two years the update has been on 8th and 9th October so news is expected next week. Hard to value the company but Mcap should be materially higher with increased oil and gas prices and hoped for production increases. Hard to assess any political risk due to locations though.
Feel sorry for those in at 10p. AIM has been brutal in recent months. For a new investor this is a buying opportunity with high reward potential but also risk if progress is slow and an equity fund raise becomes necessary albeit not until at least the end of 2022. Given the cash and very low admin costs, the financial situation should be stable.
The plus points outweigh negatives and for me are:
- the potential of the technology and more collaboration agreements
- completion of a full contract with SGSC
- low costs until R&D is stepped up
- good and regular communications, which are key for retaining support
Getting in at the right time needs a certain degree of luck but I was fortunate with Avacta, SGN, ONC and Destiny (mostly more than 2 years ago) which are all promising but show the AIM roller coaster requires a strong stomach and patience.
Only bought 80k shares but will add when have more free cash.
Tim,
As a minor SH ((400k shares) I can say that I hope the existing board will be prepared to listen to all views and not hold a grudge against those trying to change the company for the best. Hopefully also there can be a consensus on the best way forward.
Shareholders want regular and honest communication and to have some idea of what the strategic objectives and key steps are and when things will happen. Hope that's not asking too much!